LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 90.74 | 17.25 | 4005 | 6109 | 0.6555 | 0.9027 | MN20160310_N02 | K07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 90.74 | 17.25 | 8012 | 6109 | 1.3114 | 1.0651 | MN20160310_N02 | K07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 90.74 | 17.25 | 1 | 6109 | 0.0002 | -0.2856 | MN20160310_N02 | N12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 90.74 | 17.25 | 8734 | 6109 | 1.4296 | 1.0862 | MN20160310_N02 | N12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 92.71 | 17.25 | 79 | 6184 | 0.0128 | 0.1964 | MN20160310_N02 | G13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 92.71 | 17.25 | 8721 | 6184 | 1.4102 | 1.0827 | MN20160310_N02 | G13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 92.71 | 17.25 | 2830 | 6184 | 0.4576 | 0.8240 | MN20160310_N02 | K07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 92.71 | 17.25 | 8214 | 6184 | 1.3282 | 1.0680 | MN20160310_N02 | K07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 92.71 | 17.25 | 4 | 6184 | 0.0006 | -0.1582 | MN20160310_N02 | N12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 92.71 | 17.25 | 9058 | 6184 | 1.4647 | 1.0920 | MN20160310_N02 | N12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 94.68 | 17.25 | 73 | 6239 | 0.0117 | 0.1850 | MN20160310_N02 | G13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 94.68 | 17.25 | 9026 | 6239 | 1.4466 | 1.0888 | MN20160310_N02 | G13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 94.68 | 17.25 | 2175 | 6239 | 0.3486 | 0.7668 | MN20160310_N02 | K07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 94.68 | 17.25 | 8395 | 6239 | 1.3455 | 1.0711 | MN20160310_N02 | K07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 94.68 | 17.25 | 5 | 6239 | 0.0008 | -0.1356 | MN20160310_N02 | N12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 94.68 | 17.25 | 9278 | 6239 | 1.4870 | 1.0956 | MN20160310_N02 | N12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 3.06 | 17.25 | 1 | 143 | 0.0070 | -0.6065 | MN20160310_N02 | C11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 3.06 | 17.25 | 352 | 143 | 2.4579 | 1.6850 | MN20160310_N02 | C11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 3.06 | 17.25 | 1 | 143 | 0.0070 | -0.6065 | MN20160310_N02 | F12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 3.06 | 17.25 | 346 | 143 | 2.4160 | 1.6699 | MN20160310_N02 | F12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 5.03 | 17.25 | 1 | 273 | 0.0037 | -0.5106 | MN20160310_N02 | C11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 5.03 | 17.25 | 575 | 273 | 2.1035 | 1.4102 | MN20160310_N02 | C11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 5.03 | 17.25 | 1 | 273 | 0.0037 | -0.5106 | MN20160310_N02 | F12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 5.03 | 17.25 | 644 | 273 | 2.3559 | 1.4797 | MN20160310_N02 | F12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 7.01 | 17.25 | 1 | 389 | 0.0026 | -0.4692 | MN20160310_N02 | C11 |